Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

OTC Makers Target Children With Mucinex Mini Melts, Triaminic For Infants

This article was originally published in The Tan Sheet

Executive Summary

Several OTC manufacturers are focusing on the adolescent and children's markets with product launches planned for the 2006-2007 cough/cold season
Advertisement

Related Content

Triaminic Vapor Patch Adverse Events Prompt Recall By Novartis
Adams Develops New Guaifenesin Products As Mucinex Growth Continues
Adams Brings Mucinex To Pediatric Market; Humibid Launch Slated For March
Adams Brings Mucinex To Pediatric Market; Humibid Launch Slated For March
Vitamin NutriStrips Bring Delivery Alternative To Supplement Industry
Novartis Expects Thin Strips Technology To Drive OTC Cough/Cold Sales

Topics

Advertisement
UsernamePublicRestriction

Register

PS099522

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel